Figure 2.
Outcomes for 64 metastatic ampullary adenocarcinoma patients treated with either first-line fluoropyrimidine-based or gemcitabine-based chemotherapy: (A) time to progression (TTP) and (B) OS.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.